发布于: Android转发:0回复:1喜欢:0
确定你看了全文?“The United States has relied too heavily on foreign materials and bioproduction, and our past off-shoring of critical industries, including biotechnology, threatens our ability to access materials like important chemicals and active pharmaceutical ingredients”, though American maintained its strength in bioeconomy, the statement wrote.
引用:
2022-09-13 12:14
$凯莱英(SZ002821)$ $药明生物(02269)$ $金斯瑞生物科技(01548)$ 美方全文重点还是合成生物学,也未提到中国。没有中国的原料药、中间体,以及研发生产链,美国跨国药企成本将大幅上升。理论上可以全部转到印度,但这又形成单一国家依赖,供应链风险变大。美国寻求的是平衡,国内国外都有生产设施...

全部讨论

2022-09-13 23:07

大好局面毁于一“旦”